Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 212

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 212
---
 in accordance with the terms of the confidentiality agreement with such third party. Notwithstanding these restrictions, if, at any time on or after the date of the Merger Agreement, but prior to obtaining the Stockholder Approval, (1) Enfusion receives a written Acquisition Proposal from a third party, (2) such Acquisition Proposal did not result from a material breach of the no-shop provisionsof the Merger Agreement and (3) the Special Committee determines in good faith, after consultation with an Enfusion Financial Advisor and outside legal counsel, that such Acquisition Proposal constitutes, or would reasonably be expected to lead to, a Superior Proposal and that the failure to take the actions contemplated by the following clauses (x) or (y) would be inconsistent with the Special Committee’s fiduciary duties under applicable law, then Enfusion or 134

the Special Committee, directly or indirectly through one or more of their representatives, may, subject to applicable law, (x) furnish information and data with respect to Enfusion and its subsidiaries to the third party making such Acquisition Proposal and afford such third party access to the businesses, properties, assets and personnel of Enfusion and its subsidiaries and (y) enter into, maintain and participate in discussions or negotiations with the third party making such Acquisition Proposal regarding such Acquisition Proposal or otherwise cooperate with or assist or participate in, or facilitate, any such discussions or negotiations (including by entering into an Acceptable Confidentiality Agreement with such third party for the purpose of receiving non-public informationrelating to such third party); provided, however, that Enfusion (1) will not, and will cause its subsidiaries not to and will not permit its or their representatives to and will direct its and their representatives not to, furnish any non-public informationexcept pursuant to an Acceptable Confidentiality Agreement and (2) will provide to Clearwater any non-public informationconcerning Enfusion or its subsidiaries provided to such third party, which was not previously provided to Clearwater, substantially concurrently with such time it is provided to such third party. From and after the date of the Merger Agreement, Enfusion will promptly (and in any event within 24 hours) notify Clearwater of Enfusion’s receipt of any Acquisition Proposal and the identity of the Person making such Acquisition Proposal. Enfusion will thereafter keep Clearwater reasonably informed on a prompt basis (and in any event within 24 hours) of the status of any material developments regarding any such Acquisition Proposal and promptly provide Clearwater with copies of all documentation (as well as written summaries of any